MET Alterations As Resistance Mechanisms of Dabrafenib-Trametinib in BRAF P.v600e Mutated Non-Small Cell Lung Cancer Patient

Monica Pluchino,Irene Testi,Roberta Minari,Alessandra Dodi,Giulia Airo,Giulia Mazzaschi,Michela Verze,Alessia Adorni,Letizia Gnetti,Cinzia Azzoni,Costanza Anna Maria Lagrasta,Federica Pecci,Marcello Tiseo

ANTI-CANCER DRUGS（2024）

引用 0|浏览5

暂无评分

关键词

BRAF V600E,dabrafenib-trametinib,MET amplification,MET exon14 skipping mutation,non-small cell lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要